Insiders Trades
BS
Beijing Succeeder Technology Inc. Stock: price and insider trades · China
赛科希德
Beijing Succeeder Technology Inc.: what insiders have been doing
Every trade that managers of Beijing Succeeder Technology Inc. disclose to SSE / SZSE (CSRC) is tracked on this page. The company sits in the Health Care sector. The past year has been quiet: not a single insider filing for Beijing Succeeder Technology Inc. The previous disclosure was published on 23 July 2025.
The full history, which starts in 2021, counts no purchases against 20 sales.
Elsewhere in the same sector, our signals recently picked up insider purchases at MAIA Biotechnology, Inc. and Cooper Companies, Inc. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.
Insider Decl.
20
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€4M
20 ops. · all time
Who traded when
BuySale丁重辉1 sale
古小峰1 sale
张嘉翃1 sale
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 9,064 of 24,148 companies
57.7
score / 100
Value36
Quality79
FCF yld1.4%
Earn yld2.7%
EV/EBITDA29.1x
ROE5.0%
Gross mgn62%
Net mgn34%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
CN¥31.75
Analyst consensus
Income statement
RevenueCN¥263.2M
Gross profitCN¥162.4M62% margin
EBITDACN¥115.7M44% margin
Net incomeCN¥89.6M32.7% margin
Valuation
PER (trailing)39.7x
P/Book1.9x
Beta0.52
Balance sheet & cash
Market capCN¥3.4B
Total debtCN¥48k
Free Cash FlowCN¥45.7M
Debt / Equity0%
Profitability & ownership
ROE5.0%
ROA2.9%
% insiders55.6%
% institutions1.6%
Last declaration on 23 July 2025
Declarations20 total
20 of 20 declarations
About Beijing Succeeder Technology Inc.
赛科希德 is a company operating in the healthcare and pharmaceutical sector, listed on the XSHG market. It specializes in the development and marketing of pharmaceutical products.
